methysergide has been researched along with sta 2 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ikeda, K; Sasaki, H; Sasaki, T; Shimura, S; Takishima, T | 1 |
| Matsuoka, I; Nakahata, N; Nakanishi, H; Ono, T | 1 |
2 other study(ies) available for methysergide and sta 2
| Article | Year |
|---|---|
Platelet-activating factor increases platelet-dependent glycoconjugate secretion from tracheal submucosal gland.
Topics: Animals; Blood Platelets; Bridged Bicyclo Compounds, Heterocyclic; Cats; Fatty Acids, Unsaturated; Glucosamine; Glycoconjugates; Hydrazines; In Vitro Techniques; Indomethacin; Kinetics; Methysergide; Mucous Membrane; Phospholipid Ethers; Platelet Activating Factor; Radioisotope Dilution Technique; Thromboxane A2; Trachea; Tritium | 1989 |
Dominant contribution of 5-hydroxytryptamine over thromboxane A2 in contractile response of rabbit isolated aortic preparation to thrombin activated platelets.
Topics: Animals; Aorta; Blood Platelets; Blood Pressure; Female; Indomethacin; Male; Methysergide; Muscle Contraction; Muscle, Smooth, Vascular; Norepinephrine; Platelet Activation; Rabbits; Receptors, Thromboxane; Serotonin; Serotonin Antagonists; Thrombin; Thromboxane A2; Vasoconstrictor Agents | 1995 |